2035 POSTER NEAT-A: Accelerated sequential epirubicin...

2035 POSTER NEAT-A: Accelerated sequential epirubicin followed by higher dose 14 day CMF, using pegfilgrastim, is a feasible alternative for delivering dose dense E-CMF chemotherapy in early breast cancer

S. Bowden, L. Gross, C.J. Poole, L. Hiller, R.K. Agrawal, K.F. McAdam, H.M. Earl, S. Anwar, D. Rea
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
5
Year:
2007
Language:
english
DOI:
10.1016/s1359-6349(07)70797-8
File:
PDF, 81 KB
english, 2007
Conversion to is in progress
Conversion to is failed